131 results
Page 5 of 7
6-K
EX-10.1
beg2hk
12 May 20
Current report (foreign)
12:04pm
6-K
EX-4.1
bwx2tl 54o
12 May 20
Current report (foreign)
12:04pm
424B5
8pvz0k8
12 May 20
Prospectus supplement for primary offering
12:02pm
6-K
EX-10.1
5j0np51y7 r7c6
11 May 20
VBL Therapeutics Announces $10.0 Million Registered Direct Offering
9:23am
6-K
EX-4.1
5vsth0mmdjmpbf
11 May 20
VBL Therapeutics Announces $10.0 Million Registered Direct Offering
9:23am
424B5
sph51qy
11 May 20
Prospectus supplement for primary offering
9:23am
6-K
EX-99.1
ct7xp swpaxs1
26 Mar 20
VBL Therapeutics Announces Positive Outcome of the Interim Analysis in the OVAL Phase 3 Ovarian Cancer Pivotal Study
8:08am
6-K
916io0rl7xv81
14 Nov 19
Current report (foreign)
7:01am
6-K
EX-99.2
4q76lp rs
1 Nov 19
Current report (foreign)
4:15pm
6-K/A
2pzr5iif
29 Aug 19
Current report (foreign) (amended)
5:25pm
6-K
w9qs5dn
13 Aug 19
Current report (foreign)
7:00am
S-8
7lqh0w
27 Jun 19
Registration of securities for employees
4:06pm
6-K
EX-10.1
ldxep1
17 May 19
Current report (foreign)
5:20pm
424B5
5znpl
17 May 19
Prospectus supplement for primary offering
5:19pm
6-K
721owoxq79zd3iv
15 May 19
Current report (foreign)
7:00am
6-K
qth5bo j7j9a
20 Nov 18
Current report (foreign)
7:00am
6-K
EX-99.2
6c3fej
15 Oct 18
Notice of Annual General Meeting of Shareholders
8:15am